RMC
Loni, India
RMC
Loni, India

Time filter

Source Type

News Article | May 15, 2017
Site: www.prlog.org

-- Recently an innovative Bridgeport grounding product saved the day for an electrical contractor. The contractor had wired a new electric room for a hospital lab but the job failed inspection because of improper bonding.The contractor was required to install rigid metal conduit to protect the grounding electrode conductors (GEC) from physical damage between panels and the grounding electrode. The NEC requires the ferrous metal raceway (RMC) to be electrically continuous and be bonded at both ends of the raceway with the same or larger size wire to ensure the raceway and GEC are in parallel.These raceway-bonded connections are necessary so the ferrous raceway does not create an inductive choke on the grounding electrode conductor; in other words, produce resistance to the grounding systems path to earth [NEC (Articles 250.64(E) and (Exhibit 250.28)]. For this particular hospital project, the grounding electrode conductor needed to be #4/0 per NEC (Article 250.66).The contractor used a one-inch grounding bushing with #14- #4 AWG size grounding lug and #4 AWG bonding jumper. But because one-inch grounding bushings with 4/0 lugs were not available, the contractor was faced with the possibility of a major rework job.Fortunately, the project's AHJ inspector remembered seeing Bridgeport's Mighty-Bond®Equipment Grounding Hubs at an IAEI conference and recommended the solution. The contractor immediately placed an order with a Bridgeport distributor. Once in hand, using Bridgeport's one-inch MCH-100 Equipment Grounding Hub, it took just under an hour to install and pass inspection!The Mighty-Bond MCH-Series Rain tight Grounding and Bonding Hubs are part of Bridgeport's full range of electrical fittings and can be found in the" – a completely stocked selection of quality electrical fittings and innovative product solutions available from your local electrical distributorship across the U.S. and Canada.For more information about Bridgeport's other problem solving products that help contractors become more productive on the job and in the shop, contact: Bridgeport Fittings, Inc.,705 Lordship Blvd., Stratford, CT 06615; Tel: (203) 377-5944; Fax: (203) 381-3488; or visit Bridgeport's Website at http://www.bptfittings.com


News Article | May 18, 2017
Site: www.prnewswire.com

CBOE Holdings, Inc. (BATS: CBOE | NASDAQ: CBOE), owner of the Chicago Board Options Exchange, the Bats exchanges, CBOE Futures Exchange (CFE) and other subsidiaries, is one of the world's largest exchange holding companies and a leader in providing global investors cutting-edge trading and investment solutions. The company offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded funds (ETFs), and multi-asset volatility and global foreign exchange (FX) products.  CBOE Holdings' 14 trading venues include the largest options exchange in the U.S. and the largest stock exchange in Europe, and the company is the second-largest stock exchange operator in the U.S. and a leading market globally for ETF trading. CBOE Holdings is home to the CBOE Volatility Index (VIX Index), the world's barometer for equity market volatility; the CBOE Options Institute, the company's world-renowned education arm; CBOE Livevol, a leading provider of options technology, trading analytics and market data services; CBOE Vest, an asset management company specializing in target-outcome investment strategies; CBOE Risk Management Conferences (RMC), the premier financial industry forums on derivatives and volatility products; ETF.com, a leading provider of ETF news, data and analysis; and Hotspot, a leading platform for global FX trading. The company is headquartered in Chicago with offices in Kansas City, New York, London, San Francisco, Singapore and Ecuador.  For more information, visit www.cboe.com. CBOE®, Chicago Board Options Exchange®, CFE®, BATS®, Livevol®, CBOE Volatility Index® and VIX® are US registered trademarks, and CBOE Futures ExchangeSM,  CBOE VestSM and CBOE Options InstituteSM are service marks of CBOE Holdings, Inc. and its subsidiaries.  All other trademarks and service marks are the property of their respective owners. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cboe-holdings-declares-second-quarter-2017-dividend-300460437.html


News Article | May 18, 2017
Site: www.prnewswire.com

Additional information about each of the matters acted upon by shareholders at the Annual Meeting is in the proxy statement that was furnished to shareholders in connection with the meeting.  The proxy statement is also available in the Investor Relations section of www.cboe.com.  The vote totals for the matters acted upon by shareholders at the Annual Meeting will be reported in a current report on Form 8-K filing with the SEC and posted on http://ir.cboe.com. CBOE Holdings, Inc. (BATS: CBOE | NASDAQ: CBOE), owner of the Chicago Board Options Exchange, the Bats exchanges, CBOE Futures Exchange (CFE) and other subsidiaries, is one of the world's largest exchange holding companies and a leader in providing global investors cutting-edge trading and investment solutions. The company offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded funds (ETFs), and multi-asset volatility and global foreign exchange (FX) products.  CBOE Holdings' 14 trading venues include the largest options exchange in the U.S. and the largest stock exchange in Europe, and the company is the second-largest stock exchange operator in the U.S. and a leading market globally for ETF trading. CBOE Holdings is home to the CBOE Volatility Index (VIX Index), the world's barometer for equity market volatility; the CBOE Options Institute, the company's world-renowned education arm; CBOE Livevol, a leading provider of options technology, trading analytics and market data services; CBOE Vest, an asset management company specializing in target-outcome investment strategies; CBOE Risk Management Conferences (RMC), the premier financial industry forums on derivatives and volatility products; ETF.com, a leading provider of ETF news, data and analysis; and Hotspot, a leading platform for global FX trading. The company is headquartered in Chicago with offices in Kansas City, New York, London, San Francisco, Singapore and Ecuador.  For more information, visit www.cboe.com. CBOE®, Chicago Board Options Exchange®, CFE®, BATS®, Livevol®, CBOE Volatility Index® and VIX® are registered trademarks, and CBOE Futures ExchangeSM, CBOE VestSM and CBOE Options InstituteSM are service marks of CBOE Holdings, Inc. and its subsidiaries. All other trademarks and service marks are the property of their respective owners. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cboe-holdings-announces-2017-annual-meeting-results-300460302.html


News Article | May 4, 2017
Site: www.prweb.com

RMC Pharmaceutical Solutions, Inc. enhances its global expert services team with the addition of Duane Bonam and Molly Sherrard as senior consultants. Duane brings over 25 years of experience in bio-pharmaceutical process development, manufacturing support, and global CMC regulatory filings including marketing applications and post-approval changes. His expertise is with the development, scale-up and improvement of investigational and commercial manufacturing processes, process characterization, qualification and verification and QbD, viral clearance and safety issues; as well as authorship and technical review of CMC sections in regulatory filings. Before joining RMC, Duane was at Amgen for over 15 years. As a Scientific Director, he supported late-stage development and commercial processes, implementation of QbD, and participated in the FDA QbD pilot program. Prior to Amgen, Duane was at Wyeth (formerly Genetics Institute) where he helped develop the purification process for recombinant Factor IX and provided ongoing commercial life-cycle support. Duane received his Ph.D. in biochemistry from the University of Wisconsin, and a B.S in chemistry/biochemistry from the University of Illinois. “As RMC’s global reputation for excellence continues to grow, Duane brings valuable strategic and tactical CMC experience to RMC,” said Timothy Joy, President of RMC. “Duane’s depth of experience in highly successful programs, lets him hit the ground running with practical, knowledgeable hands-on execution and assistance that our clients have come to expect from RMC. Several of our staff have worked with Duane in the past, and we’re confident that he will fit in well with RMC’s “Bolt On” strategy for CMC development for all kinds of pharmaceutical and biological products” Molly comes to RMC with over 18 years of pharmaceutical experience gained across technical and leadership roles at several large-scale API manufacturing and drug product packaging sites. Prior to joining RMC, Molly established her adaptive skillsets with successful roles as a production engineer, manager API manufacturing and operational excellence at Pfizer; and manager of packaging technology and project manager at Bristol-Myers Squibb and AstraZeneca. She also brings extensive experience with quality investigations, process improvement, new product launches, packaging line startup, general technical operations support and multiple implementation options to meet global product serialization expectations. Molly received a Bachelor of Science in Chemical Engineering from the University of Kentucky, as well as training in the Rath & Strong Method 4 Lean methodology and Project Management Professional certification from the Project Management Institute. “Molly’s solid engineering background and technical project management leadership, which transcends both API manufacturing and drug product packaging systems, is exemplified in her cross-functional adaptability and expertise,” said Timothy Joy, President of RMC. “We expect that Molly’s broad background, commitment to success and her contemporary understanding of key global product packaging and commercialization challenges, will have an immediate positive impact on our RMC teams and the clients they support.” Founded in 2004, RMC is the privately-held global leader providing Bolt-on CMC™ expert services to the pharmaceutical, biotechnology, medical device and allied industries. RMC was founded to provide comprehensive services to companies developing and commercializing health care products and has now served more than 150 different clients across North America, Europe and Asia. Through our Bolt-on CMC™ expert services offering, RMC provides an experienced integrated team to directly support Chemistry, Manufacturing and Control (CMC) areas such as process, analytical and formulation development; quality control/quality assurance; and oversight of GMP manufacturing. RMC experts also support the full range of pharmaceutical development and commercialization of GxP activities. Our clients have access to the considerable expertise of the RMC team, as well as physical assets; including an analytical and process development laboratory, document management, and advanced software tools. For more information about RMC and how we can help you, please visit http://www.rmcpharma.com.


News Article | May 5, 2017
Site: globenewswire.com

DANVERS, Massachusetts, May 05, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), provedora líder de tecnologias inovadoras de suporte cardíaco, anunciou hoje o cadastro do primeiro paciente no estudo de viabilidade prospectivo, aprovado pela Food and Drug Administration (FDA), IMEST Door to Unloading (DTU), com o sistema Impella CP®, em infarto agudo do miocárdio. Esse teste irá concentrar-se na viabilidade e segurança de descarga do ventrículo esquerdo utilizando a bomba cardíaca CP antes da intervenção coronária percutânea (ICP) primária em pacientes que apresentam infarto do miocárdio com elevação do segmento ST (IMEST) sem choque cardiogênico, com a hipótese de que isso irá potencialmente reduzir a dimensão do infarto. A pesquisa, que recebeu aprovação da FDA em outubro de 2016, é um estudo de viabilidade prospectivo e multicêntrico conduzido pelos pesquisadores principais Dr. Navin K. Kapur, do Tufts Medical Center, e Dr. William W. O'Neill, do Henry Ford Medical Center. Até 50 pacientes em 10 locais serão cadastrados no estudo, cuja estimativa de conclusão é de 18 meses. O primeiro paciente no estudo foi cadastrado no final de abril, no Northwell Health System, em Long Island, NY, sob a liderança do Dr. Perwaiz Meraj. Os objetivos principais do estudo de viabilidade irão concentrar-se na segurança, incluindo Eventos cardiovasculares e cerebrovasculares adversos (ECCAM), em 30 dias. Todos os pacientes serão submetidos a imagiologia de ressonância magnética cardíaca (RMC) para avaliar a dimensão do infarto como porcentagem de massa do ventrículo esquerdo 30 dias após a ICP. Os pacientes serão escolhidos aleatoriamente para colocação do Impella CP com ICP primária imediata, ou para colocação do Impella CP com 30 minutos de descarga antes da IPC primária. A hipótese dessa nova abordagem para tratamento de pacientes com IMEST, baseada em uma ampla pesquisa mecanicista, é a de que a descarga do ventrículo esquerdo antes da ICP reduz a carga de trabalho do miocárdio e a demanda de oxigênio e também inicia um efeito cardioprotetor no nível celular do miocárdio, que pode atenuar o dano ao miocárdio causado por lesão de reperfusão no momento da revascularização. Esse estudo de viabilidade irá ajudar a refinar o protocolo e criar as bases para um futuro importante estudo com mais locais e pacientes e será criado para significância estatística. A Abiomed não planeja anunciar status adicionais de cadastramento. O logo da ABIOMED, ABIOMED, Impella, Impella 2.5, Impella CP, Impella 5.0, Impella RP e Recovering Hearts. Saving Lives. são marcas comerciais registradas da ABIOMED, Inc. nos EUA e em outros países. O registro cVAD é uma marca comercial da ABIOMED, Inc. SOBRE A ABIOMED  Baseada em Danvers, Massachusetts, a Abiomed, Inc. é uma provedora líder de dispositivos médicos que oferecem suporte circulatório. Nossos produtos são projetados para permitir que o coração descanse ao melhorar o fluxo sanguíneo e/ou realizar o bombeamento do coração. Para obter informações adicionais, acesse: www.abiomed.com DECLARAÇÕES PROSPECTIVAS  Esse comunicado contém declarações prospectivas, incluindo declarações em relação ao desenvolvimento dos atuais produtos da Abiomed e de novos produtos, ao progresso da Empresa rumo ao crescimento comercial e futuras oportunidades e aprovações regulatórias esperadas. Os resultados reais da Empresa podem diferir materialmente dos que foram antecipados nessas declarações prospectivas com base em vários fatores, incluindo incertezas associadas com desenvolvimento, testes e aprovações regulatórias relacionadas, incluindo a possibilidade de futuras perdas, fabricação complexa, requisitos de alta qualidade, dependência de fontes de suprimento limitadas, competição, alteração tecnológica, regulamentação governamental, litígios, necessidade futura de capital e incerteza de financiamento adicional e outros riscos e desafios detalhados nos registros da Empresa na Comissão de Títulos e Câmbio, incluindo o registro do Relatório Anual mais recente no Formulário 10-K e do Relatório trimestral no Formulário 10-Q. Os leitores são advertidos a não depositarem confiança indevida em qualquer declaração prospectiva, que vale apenas a partir da data deste comunicado. A Empresa não assume qualquer obrigação de divulgar publicamente os resultados de qualquer revisão dessas declarações prospectivas, o que pode ser feito para refletir eventos ou circunstâncias que ocorram após a data deste comunicado ou refletir a ocorrência de eventos imprevistos.


News Article | May 8, 2017
Site: www.prnewswire.com

BMC is designed to challenge this dynamic. Under the current proposal, participants can elect to route Market-On-Close (MOC) orders to BMC on Bats' BZX Exchange, where they are pre-matched with other MOC orders at 3.35 p.m. ET. Pre-matched trades are then executed when the primary exchange closing price is published. As a result, participants obtain a closing price for a fraction of the cost. Further, the timing of the BMC match allows any MOC orders that go unmatched to be sent to the primary exchange closing auctions. A variety of brokers already provide Market-On-Close prices for investors. Subject to regulatory approval, BMC will be the first such functionality to be offered by an equity venue operator, incorporating unique on-exchange features including anonymity and trade transparency. Bryan Harkins, Head of U.S. Equities and Global FX said: "Over the past few years, we have seen the primary market auction operators steadily increasing auction fees while, conversely, intraday exchange trading fees have steadily dropped as a result of competition. This has made a critical part of the trading day markedly more expensive. As a result, market participants have asked us to provide competitive pressure of the sort that we apply during the trading day. The Bats Market Close is our response that provides an alternative that reduces costs for market orders but preserves a single, consolidated closing price, all through an exchange platform." Most importantly, the BMC does not create a rival, price-forming auction for non-listed securities. This is because the BMC avoids removing Limit-On-Close orders from forming price in the primary market closing auctions, only matching market-on-close orders. This reduces participant costs without distorting auction price formation. CBOE Holdings, Inc. (BATS: CBOE | NASDAQ: CBOE), owner of the Chicago Board Options Exchange, the Bats exchanges, CBOE Futures Exchange (CFE) and other subsidiaries, is one of the world's largest exchange holding companies and a leader in providing global investors cutting-edge trading and investment solutions. The company offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded funds (ETFs), and multi-asset volatility and global foreign exchange (FX) products.  CBOE Holdings' 14 trading venues include the largest options exchange in the U.S. and the largest stock exchange in Europe, and the company is the second-largest stock exchange operator in the U.S. and a leading market globally for ETF trading. CBOE Holdings is home to the CBOE Volatility Index (VIX Index), the world's barometer for equity market volatility; the CBOE Options Institute, the company's world-renowned education arm; CBOE Livevol, a leading provider of options technology, trading analytics and market data services; CBOE Vest, an asset management company specializing in target-outcome investment strategies; CBOE Risk Management Conferences (RMC), the premier financial industry forums on derivatives and volatility products; ETF.com, a leading provider of ETF news, data and analysis; and Hotspot, a leading platform for global FX trading. The company is headquartered in Chicago with offices in Kansas City, New York, London, San Francisco, Singapore and Ecuador.  For more information, visit www.cboe.com. CBOE®, Chicago Board Options Exchange®, CFE®, BATS®, Livevol®, CBOE Volatility Index® and VIX® are registered trademarks, and CBOE Futures ExchangeSM, CBOE VestSM and CBOE Options InstituteSM are service marks of CBOE Holdings, Inc. and its subsidiaries. All other trademarks and service marks are the property of their respective owners. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bats-announces-alternative-to-closing-auctions-300453047.html


News Article | May 4, 2017
Site: www.prnewswire.com

"After welcoming VelocityShares' EVIX ETNs to our Bats ETF Marketplace (http://ir.cboe.com/press-releases/2017/05-03-2017.aspx), and thereby packaging European volatility into exchange-traded products for the first time, we are now excited to offer EVIX options," said John Deters, CBOE's Chief  Strategy Officer and Head of Multi-Asset Solutions.  "The new options highlights how our recent acquisition of Bats Global Markets enables us to work with issuers as a one-stop-shop to develop, list, and trade ETN and ETF products.   We are particularly pleased that the first options on ETNs to be offered under the combined company expand our global volatility offering." CBOE Holdings, Inc. (BATS: CBOE | NASDAQ: CBOE), owner of the Chicago Board Options Exchange, the Bats exchanges, CBOE Futures Exchange (CFE) and other subsidiaries, is one of the world's largest exchange holding companies and a leader in providing global investors cutting-edge trading and investment solutions. The company offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded funds (ETFs), and multi-asset volatility and global foreign exchange (FX) products.  CBOE Holdings' 14 trading venues include the largest options exchange in the U.S. and the largest stock exchange in Europe, and the company is the second-largest stock exchange operator in the U.S. and a leading market globally for ETF trading. CBOE Holdings is home to the CBOE Volatility Index (VIX Index), the world's barometer for equity market volatility; the CBOE Options Institute, the company's world-renowned education arm; CBOE Livevol, a leading provider of options technology, trading analytics and market data services; CBOE Vest, an asset management company specializing in target-outcome investment strategies; CBOE Risk Management Conferences (RMC), the premier financial industry forums on derivatives and volatility products; ETF.com, a leading provider of ETF news, data and analysis; and Hotspot, a leading platform for global FX trading. The company is headquartered in Chicago with offices in Kansas City, New York, London, San Francisco, Singapore and Ecuador.  For more information, visit www.cboe.com. CBOE®, Chicago Board Options Exchange®, CFE®, BATS®, Livevol®, CBOE Volatility Index® and VIX® are US registered trademarks, and CBOE Futures ExchangeSM, EVIXSM, CBOE VestSM and CBOE Options InstituteSM are service marks of CBOE Holdings, Inc. and its subsidiaries. VelocityShares® is a US registered trademark of VelocityShares, LLC. Euro STOXX 50® is an EU registered trademarks of STOXX AG. All other trademarks and service marks are the property of their respective owners. CBOE Holdings and its affiliates do not recommend or make any representation as to possible benefits from any securities or investments, or third-party products or services. Investors should undertake their own due diligence regarding their securities and investment practices. You cannot invest directly in an index. This press release speaks only as of this date. We disclaim any duty to update the information herein. Nothing in this announcement should be considered a solicitation to buy or an offer to sell any securities in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction. Nothing contained in this communication constitutes tax, legal or investment advice. Investors must consult their tax adviser or legal counsel for advice and information concerning their particular situation. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cboe-begins-trading-options-on-velocityshares-evix-300451739.html


News Article | February 15, 2017
Site: www.prweb.com

Mike is a project manager, consultant, and author. He is also a regular columnist at ProjectManagement.com. He holds multiple project management and Agile-related certifications, including the PMI Agile Certified Practitioner (PMI-ACP)® designation. Mike’s career spans many disciplines, and he has a variety of accomplishments. In 1994, he was involved in creating the agile Dynamic Systems Development Method (DSDM) and has been using agile methods including Feature Driven Development (FDD), Scrum and XP for the last 23 years. He served on the Board of Directors for the Agile Alliance and the board of the Agile Project Leadership Network (APLN). In addition to Agile methods, Mike is interested and active in traditional project management. He holds PRINCE2 and Project Management Professional (PMP)® certifications and is a contributor to the Project Management Body of Knowledge (PMBOK® Guide), Third Edition through Sixth Edition. Mike was a co-author of the Software Extension to the PMBOK® Guide and is currently chair of the PMI Committee to create the upcoming PMI Agile Practice Guide. Mike is a faculty member at the University of Calgary where he teaches in the Masters of Science Software Engineering program. He is also a frequent contributor to project management and agile publications including Cutter Consortium, Agile Journal and ProjectManagement.com. He is also engaged in his local PMI Chapter where he has been recognized for the following awards from PMI: 2005 - Winner - PMI-SAC Award - “Distinguished Contribution by an Individual,” 2007 - Winner - PMI-SAC Award - “Best Project Management Literature,” 2010 - Winner - PMI-SAC Award - “Project of the Year,” 2013 - IEEE Computer Society - "Outstanding Contribution Award" 2014 - Recipient – PMI-SAC Fellow – “ Contributions to the field of Project Management” Founded by Rita Mulcahy in 1991, RMC is the worldwide innovator in Project Management, Business Analysis and Agile training and professional development. Over the last 20+ years, hundreds of thousands of students in over 60 regions across the globe have utilized one of RMC's proprietary professional development resources, classes, or eLearning courses to expand their knowledge and further their careers. Today, RMC offers a wide range of innovative project management, business analysis and agile classes and products to help beginners, advanced practitioners, and experienced professionals improve their skills and knowledge as well as prepare for certification.


News Article | February 15, 2017
Site: www.prweb.com

Bluetick will be exhibiting at the 2017 North American Prospect Expo, scheduled for Feb. 16-18 at the George R. Brown Convention Center in Houston, Texas. NAPE Summit 2017 is a networking event that brings together all the players necessary to forge, facilitate and close deals. In the upstream oil and gas business, it is the largest and most successful event of its kind in the world. Bluetick's solution is proven in the oil and gas industry. They employ the most talented software developers and engineers to architect, integrate and support their dependable systems. Bluetick's Land Management System software is an intuitive solution. It's a real-time, tract-based integrated land administration system that manages the entire life cycle of permit and lease acquisition projects, all in one web-based package. In addition, the integrated Esri ArcGIS® mapping functionality ensures that the user can easily provide detailed maps to stakeholders. About the Company: Bluetick Inc. provides remote monitoring and control automation solutions to the midstream and upstream oil and gas marketplace. Bluetick’s Remote Monitoring and Control (RMC) system solutions helps operators optimize oil and gas production, enhance environmental compliance and safety, and increase workforce performance. Bluetick’s Land Management System (LMS) software automates the entire lifecycle of permit, lease, and ROW acquisition projects, including land records administration and complete GIS mapping interface. For more information please visit our website http://www.bluetickinc.com.


News Article | February 17, 2017
Site: www.marketwired.com

This press release is not to be distributed to U.S. newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities law. As announced on December 21, 2016, RMC GP Inc. ("RMC"), an affiliate of Resource Merchant Capital Corp., an Alberta-based private capital firm, has invested $1.175 million in Acceleware Ltd. (TSX VENTURE: AXE) ("Acceleware"). Pursuant to the closing of a private placement (the "Offering") by Acceleware of convertible debentures as set out in Acceleware's news release dated December 19, 2016, RMC acquired a convertible debenture in the principal amount of $675,000 (the "Debenture"). The Debenture is convertible into units of Acceleware at a conversion price equal to the lesser of (i) $0.15 per unit, and (ii) if Acceleware, at any time after December 16, 2016, distributes common shares ("Shares") in the capital of Acceleware, the price per Share, provided the conversion occurs within 15 days of the announcement of such distribution, and under no circumstances will the conversion price be lower than $0.12. Each unit consists of one Share in the capital of Acceleware and one-half of one Share purchase warrant of Acceleware (the "December Warrants"). Each whole December Warrant entitles RMC to acquire one Share in the capital of Acceleware, at an exercise price equal to two times the conversion price of the units, for a 24-month period following the distribution of the Debenture. The Debenture can be converted at the option of Acceleware provided that on the date of conversion, the 30-day volume weighted average trading price of the Shares of Acceleware on the TSX Venture Exchange is equal to or greater than 150% of the conversion price. Interest on the Debenture accrues at a rate of 10% per annum, and the maturity date of the Debenture is December 16, 2020. Prior to October 7, 2016, RMC did not have ownership or control over any securities of Acceleware. On October 7, 2016, RMC acquired 4,545,455 Shares and 2,272,727 Share purchase warrants (the "October Warrants"), each October Warrant entitling RMC to acquire one Share of Acceleware at an exercise price of $0.22, for a period ending on October 7, 2018. Assuming the conversion of the entire principal amount of the Debenture, the October Warrants, and the December Warrants, RMC would have ownership and control over an aggregate of 13,568,182 Shares, or 12.4% of the issued and outstanding Shares on a fully-diluted basis. RMC relied on Section 2.3 of National Instrument 45-106 - Prospectus Exemptions as RMC meets the definition of "accredited investor" under securities legislation. The Debenture was acquired by RMC for investment purposes. RMC may, from time to time, depending on market and other conditions or relevant factors, increase or decrease its beneficial ownership, control or direction over securities of Acceleware through market transactions, private agreements or otherwise. RMC has filed a report (as contemplated by National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues) in connection with the acquisition of the Debenture under the Offering. A copy of the report may be obtained from SEDAR (www.sedar.com). Nothing in this press release or in the filing of the above-mentioned report is an admission that any person named in the report is a joint actor with another named entity. Resource Merchant Capital (www.resourcemc.com) is an Alberta-based, private capital firm focused exclusively on oil and gas product and service companies. Resource Merchant Capital partners with technology-focused companies to build world class businesses that drive significant wealth for founders, entrepreneurs, leaders and shareholders. Acceleware (www.acceleware.com) develops high performance seismic imaging and modeling software products and provides innovative technology for radio frequency (RF) heating, an emerging thermal enhanced oil recovery method. As experts in programming for multi-core CPUs and massively parallel GPUs, Acceleware's professional services team specializes in accelerating computationally intense applications for clients to speed up product design, analyze data and help make better business decisions. Acceleware's products and services are used by some of the world's largest energy and engineering companies. Acceleware is a public company on Canada's TSX Venture Exchange under the trading AXE. For further information: Resource Merchant Capital, Chad Robinson, Tel: +1 (403) 993-9986, crobinson@resourcemc.com, www.resourcemc.com; Acceleware Ltd., Geoff Clark, Tel: +1 (403) 249-9099, geoff.clark@acceleware.com, www.acceleware.com. This press release contains "forward-looking information" within the meaning of Canadian securities legislation. Forward-looking information generally means any information about Acceleware or RMC that is prospective in nature, and often includes words such as "anticipates", "expects", "estimates", "intends" and words and terms of similar substance, in connection with discussions about RMC's or Acceleware's future operations or financial performance. Actual results may vary from the forward-looking information in this press release due to certain material risk factors. Neither Acceleware nor RMC assumes any obligation to update or revise the forward-looking information in this press release, unless it is required to do so under Canadian securities legislation. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Loading RMC collaborators
Loading RMC collaborators